Tsumura & Co.

Tokyo Stock Exchange 4540.T

Tsumura & Co. Cash and Short-Term Investments for the year ending March 31, 2024: USD 515.84 M

Tsumura & Co. Cash and Short-Term Investments is USD 515.84 M for the year ending March 31, 2024, a -27.67% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.
  • Tsumura & Co. Cash and Short-Term Investments for the year ending March 31, 2023 was USD 713.20 M, a 28.52% change year over year.
  • Tsumura & Co. Cash and Short-Term Investments for the year ending March 31, 2022 was USD 554.94 M, a 0.24% change year over year.
  • Tsumura & Co. Cash and Short-Term Investments for the year ending March 31, 2021 was USD 553.63 M, a -3.91% change year over year.
  • Tsumura & Co. Cash and Short-Term Investments for the year ending March 31, 2020 was USD 576.14 M, a -11.57% change year over year.
Key data
Date Cash and Short-Term Investments Receivables Inventory Goodwill
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4540.T

Tsumura & Co.

CEO Mr. Terukazu Kato
IPO Date Jan. 1, 2001
Location Japan
Headquarters 2-17-11, Akasaka
Employees 4,138
Sector Healthcare
Industries
Description

Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.

Similar companies

4521.T

Kaken Pharmaceutical Co., Ltd.

USD 27.19

-2.00%

4507.T

Shionogi & Co., Ltd.

USD 14.75

-0.46%

4506.T

Sumitomo Pharma Co., Ltd.

USD 3.93

2.09%

4530.T

Hisamitsu Pharmaceutical Co., Inc.

USD 28.70

-1.67%

4516.T

Nippon Shinyaku Co., Ltd.

USD 24.26

-0.77%

StockViz Staff

February 3, 2025

Any question? Send us an email